Xu Ning, Zhang Bei-Bei, Huang Xia-Ning, Yi Xiang, Yan Xue-Min, Cai Yan, He Qin, Han Zi-Jian, Huang Yuan-Jiao, Liu Wei, Jiao Ai-Jun
The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, China.
Institute of Biomedical Research, Yunnan University, Kunming, China.
Bioinorg Chem Appl. 2021 Jun 22;2021:9913794. doi: 10.1155/2021/9913794. eCollection 2021.
Nasopharyngeal carcinoma (NPC) is one type of malignancy associated with migration and invasion through a currently unclear mechanism. We previously discovered S100A8/A9 levels were roughly elevated in the plasma of NPC patients as the promising biomarkers. However, their expressions and underlying functions in NPC tissues are still unknown. In the present study, we analyzed 49 NPC tissues and 20 chronic pharyngitis (CP) tissues. Immunohistochemical staining was performed in different tissues and analyzed by the Mann-Whitney test statistically. Transwell migration and invasion experiments were further performed to determine S100A8/A9 effects on NPC. Our results showed that S100A8/A9 in NPC tissues were significantly higher than those in CP tissues, closely associated with NPC clinical stages. Intriguingly, exogenous S100A8/A9 protein stimulation could dramatically enhance NPC migration and invasion abilities. In addition, p38 MAPK pathway blockade could diminish the migration and invasion of NPC cells stimulated by S100A8/A9 proteins. The downstream tumor invasion and migration associated proteins (e.g., MMP7) were also elevated in NPC tissues, consistent with S100A8/A9 overexpression. Taken together, our present findings suggest that the secreted soluble inflammatory factors S100A8/A9 might promote cancer migration and invasion via the p38 MAPK signaling pathway along with invasion/migration associated proteins overexpression in the tumor microenvironment of NPC. This may shed light on the mechanism understanding of NPC prognosis and provide more novel clues for NPC diagnosis and therapy.
鼻咽癌(NPC)是一种通过目前尚不清楚的机制与迁移和侵袭相关的恶性肿瘤。我们之前发现,作为有前景的生物标志物,鼻咽癌患者血浆中的S100A8/A9水平大致升高。然而,它们在鼻咽癌组织中的表达及其潜在功能仍然未知。在本研究中,我们分析了49例鼻咽癌组织和20例慢性咽炎(CP)组织。对不同组织进行免疫组织化学染色,并通过曼-惠特尼检验进行统计学分析。进一步进行Transwell迁移和侵袭实验以确定S100A8/A9对鼻咽癌的影响。我们的结果表明,鼻咽癌组织中的S100A8/A9明显高于慢性咽炎组织,与鼻咽癌临床分期密切相关。有趣的是,外源性S100A8/A9蛋白刺激可显著增强鼻咽癌的迁移和侵袭能力。此外,p38丝裂原活化蛋白激酶(MAPK)途径阻断可减少S100A8/A9蛋白刺激的鼻咽癌细胞的迁移和侵袭。下游肿瘤侵袭和迁移相关蛋白(如基质金属蛋白酶7)在鼻咽癌组织中也升高,与S100A8/A9过表达一致。综上所述,我们目前的研究结果表明,分泌的可溶性炎症因子S100A8/A9可能通过p38 MAPK信号通路以及鼻咽癌肿瘤微环境中侵袭/迁移相关蛋白的过表达促进癌症迁移和侵袭。这可能有助于深入了解鼻咽癌预后的机制,并为鼻咽癌的诊断和治疗提供更多新线索。